Supernus Pharmaceuticals, Inc. Uncategorized Contracts & Agreements
20 Contracts & Agreements
- Exhibit 10.1+ Offer Letter to Timothy C. Dec (Filed With SEC on July 29, 2021)
- Offer Letter to James P. Kelly (Filed With SEC on October 5, 2020)
- Additional Convertible Bond Hedge Transaction, dated March 15, 2018, between JPMorgan Chase Bank, National Association, London Branch and Supernus Pharmaceuticals, Inc (Filed With SEC on March 20, 2018)
- Additional Convertible Bond Hedge Transaction, dated March 15, 2018, between Bank of America, N.A. and Supernus Pharmaceuticals, Inc (Filed With SEC on March 20, 2018)
- Additional Convertible Bond Hedge Transaction, dated March 15, 2018, between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc (Filed With SEC on March 20, 2018)
- Base Convertible Bond Hedge Transaction, dated March 14, 2018, between JPMorgan Chase Bank, National Association, London Branch and Supernus Pharmaceuticals, Inc (Filed With SEC on March 20, 2018)
- Base Convertible Bond Hedge Transaction, dated March 14, 2018, between Bank of America, N.A. and Supernus Pharmaceuticals, Inc (Filed With SEC on March 20, 2018)
- Base Convertible Bond Hedge Transaction, dated March 14, 2018, between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc (Filed With SEC on March 20, 2018)
- CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. (Filed With SEC on May 9, 2017)
- CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. (Filed With SEC on May 9, 2017)
- CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. (Filed With SEC on May 9, 2017)
- CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. (Filed With SEC on March 9, 2016)
- Supernus to Receive $30 Million in Non-Dilutive Royalty Deal (Filed With SEC on July 8, 2014)
- CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. (Filed With SEC on July 8, 2014)
- CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. (Filed With SEC on August 21, 2013)
- COMPENSATORY ARRANGEMENTS WITH EXECUTIVE OFFICERS (Filed With SEC on November 2, 2012)
- COMPENSATORY ARRANGEMENTS WITH EXECUTIVE OFFICERS (Filed With SEC on November 2, 2012)
- OFFER LETTER TO EXECUTIVE OFFICER (Filed With SEC on November 2, 2012)
- Supernus Pharmaceuticals, Inc. 1550 East Gude Drive, Rockville, MD 20850 USA Phone: (301) 838-2500 Fax: (301) 838-2501 www.supernuspharma.com (Filed With SEC on March 16, 2012)
- Supernus Pharmaceuticals, Inc. 1550 East Gude Drive, Rockville, MD 20850 USA Phone: (301) 838-2500 Fax: (301) 838-2501 www.supernuspharma.com (Filed With SEC on March 16, 2012)
